MKM Upgrades Merck to a "Buy" (MRK)

MKM Upgrades Merck to a “Buy” (MRK)

RSS

MKM reported on Tuesday that they have upgraded healthcare company, Merck & Co., Inc.(MRK) to a “Buy”.

The firm reported that they have upgraded MRK from “Neutral” to a “Buy,” and have given the company a price target of $51. This price target suggests a 15% increase over the stock’s current price of $43.38.

Merck & Co. shares were mostly flat during premarket trading Tuesday. The stock is up 14.96% YTD.

The Bottom Line
Shares of Merck (MRK) have a 3.81% dividend yield, based on last night’s closing stock price of $43.34. The stock has technical support in the $41-$42 price area. If the shares can firm up, we see overhead resistance around the $46-$48 price levels.

Merck & Co., Inc.(MRK) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today